Outcomes of Clareon PanOptix Pro in Patients With Prior Myopic Refractive Surgery

Who May Qualify: - Adults (45 years or older) who have confirmed age-related cataracts and are eligible for bilateral cataract surgery. - Prior binocular myopic photorefractive keratectomy (PRK) or myopic LASIK. - Patients who have regular corneal astigmatism less than or equal to 0.6 D and are candidates for the PanOptix Pro spherical IOL. - Patients who have regular corneal astigmatism and are candidates for PanOptix Pro toric IOL T3 - Postoperative visual potential of monocular 20/25 or better, in the surgeon's judgement. Who Should NOT Join This Trial: - Any ocular comorbidity that might hamper postoperative visual acuity: - Corneal abnormality including corneal dystrophy, irregularity, and degeneration. - Moderate or severe dry eyes that can't be relieved after treatment. - History of or current anterior and posterior inflammation of any etiology. - Retinal pathology such as AMD, diabetic retinopathy, vein occlusion, etc. - Glaucoma of any kind. - Pregnancy or lactation. - Any ocular surgery other than corneal myopic refractive surgery (LASIK and PRK). - Patients with physical or intellectual disability (e.g. Down's Syndrome, Parkinson's Disease, unable to fixate) - Apple Kappa/chord mu ≥ 0.6. - Higher order corneal aberrations at pupil diameter of 4mm: \> 0.6 total RMS, \> 0.3 coma, \> 0.3 trefoil (to exclude irregular corneas) - Any patient requiring a limbal relaxing incision. The principal investigator reserves the right to declare a patient ineligible or non-evaluable based on medical evidence that indicates they are unsuitable for the trial. Always talk to your doctor about whether this trial is right for you.